Navigation Links
Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices
Date:10/21/2008

Company Will Take $1.415 Billion Charge in Third Quarter 2008

INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that it is in advanced discussions to resolve the ongoing investigations led by the U.S. Attorney's Office for the Eastern District of Pennsylvania (EDPA) related to past U.S. marketing and promotional practices for its antipsychotic medication Zyprexa(R) (olanzapine). As a result, the company will record in the third quarter of 2008 a charge of $1.415 billion, or $1.29 per share.

The Government's investigation is related to past marketing and promotional practices for Zyprexa in the United States. Lilly has now incorporated an enhanced compliance program that is designed to ensure that the company's global marketing and promotional practices fully comply with all laws and regulations. Lilly's compliance program includes the elements of compliance guidelines issued by the Department of Health and Human Services, Office of Inspector General, for the pharmaceutical industry. The company has a vice president and chief compliance officer, who reports directly to Lilly's chief executive officer; corporate compliance committee; a code of conduct; policies and procedures specific to promotion and marketing; extensive training; auditing, monitoring and reporting programs, including a compliance hotline; and disciplinary and corrective action processes.

"Lilly's compliance programs are comprehensive and demonstrate that compliance is a top priority of the company," said Robert A. Armitage, Lilly's senior vice president and general counsel. "The government's investigation of Zyprexa has been ongoing for five years and we now have a heightened sense of responsibility to
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009).... 6 Helix BioPharma Corp...ounced that John Docherty, president and chief ope...rd,s 6th annual Investor Summit on November 10, 20...y. Mr. Docherty will provide an overview of the C...S47 and Topical Interferon Alpha-2b. The slide sh...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...ideas passed muster in the first round of the Gove...ednesday. , ,They were chosen from 188 submissions...their businesses and represent various municipalit...kee areas. , ,That,s down from 200 entries last ye...gher, chairman of the Wisconsin Technology Council...
...in break Thursday at the Milwaukee County Grounds ...iday to 37 companies in the Milwaukee County Resea...rks director of development said businesses in the...nconvenience. , ,Guy T. Mascari, whose office is l...ation Center, said the center is the only building...
...lor of research in the history of the University o...ng to change its image from a university of access...elp Milwaukee build a knowledge-based economy. , ,...Wisconsins 2006 Technology Achievement Awards, app...ive. Citing Atlanta as a potential model, he said ...
Other Biology Technology:Tech awards keynoter asks for support of UWM transformation 2Tech awards keynoter asks for support of UWM transformation 3
(Date:11/4/2009)..., N.Y., Oct. 21 What,s the cost of...g accidental death resulting from prescription med...good intentions, however, may be unaware that the ...eir teens from the ticking timebomb of prescriptio...in premium-quality medical supplies, has formed an...
(Date:11/4/2009)...APEL HILL Scientists at the University of North C...University of California, San Francisco have devel...ict new target diseases for existing drugs. , Th...t compares how similar the structures of all known...ners -- known as ligands -- of disease targets wit...
(Date:11/3/2009)... RATON, FL (November 4, 2009) For more than 25 ye...en conch ( Strombus gigas ) have been unsuccessful...ry seeding techniques to produce beaded (nucleated...nch have been developed by scientists from Florida... Institute (HBOI). With less than two years of res...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3HPV vaccine could prevent breast cancer 3A Australian research 56154 1HPV vaccine could prevent breast cancer 3A Australian research 56154 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3NIBIB scientists increase imaging efficiency in cell structure studies 56150 1NIBIB scientists increase imaging efficiency in cell structure studies 56150 2
...single vaccine could be used to protect chickens, ...rding to an article published in the November issu...e protects birds and mammals against different flu... are still in their eggs, allowing the mass vaccin...has posed a major challenge to scientists designin...
...In a disease like ALS - one that,s always fatal an...ology - finding a proof of principle in animal mod...searchers report that transplanting a new line of ...e clearly shifts key signs of neurodegenerative di...he animals, neuron loss and extending life. , The...
...searchers at Emory University and Georgia Institut...that can slowly release anti-inflammatory drugs an...jected into rats, hearts after a simulated heart a...nflammation and scarring, the researchers found.,I...tissue formed after the heart attack in half and b...
Other Biology News:Bird flu vaccine protects people and pets 2Swamping bad cells with good in ALS animal models helps sustain breathing 2Swamping bad cells with good in ALS animal models helps sustain breathing 3Drug-embedded microparticles bolster heart function in animal studies 2
...onoclonal [198C679.2.1] to Presenilin 2 Alzheimer... the disease carry mutations in the presenilin pro...ein (APP). These disease-linked mutations result i...id-beta (main component of amyloid deposits found ...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: